Healthcare Investment Banks by Company Size and Transaction Type
Choosing the right healthcare investment bank is less about brand recognition and more about fit. Investment banks are purpose-built to serve different market segments, defined primarily by company size, transaction value, and buyer universe. A bank that excels in $2 billion public-company transactions is not necessarily the right advisor for a $50 million founder-owned healthcare services business, and vice versa.
Below, we break down the healthcare investment banking landscape by market segment, highlighting the types of companies each group serves and the firms that lead in each category.
Disclaimer: This analysis reflects our opinion based on publicly available information and market research. It is for informational purposes only, does not constitute investment advice, and does not guarantee outcomes. Readers should conduct their own due diligence when selecting an investment bank.
Market Segmentation Overview
| Market Segment | Typical Transaction Size | EBITDA Range | Typical Clients | Representative Advisors |
|---|---|---|---|---|
| Bulge Bracket | $1B+ | $100M+ | Public companies, mega-cap PE | Goldman Sachs J.P. Morgan |
| Core/Upper Middle Market | $200M–$1B | $20–100M | PE-backed platforms | Houlihan Lokey William Blair Cain Brothers TripleTree Piper Sandler |
| Lower Middle Market | $20M–$200M | $2–20M | Founder-owned healthcare services | FOCUS Investment Banking |
| Small Transactions | <$20M | <$2M | Small, owner-operated businesses | Transworld Business Brokers |
Bulge Bracket Healthcare Transactions
($1B+ transactions, $100M+ EBITDA)
Bulge bracket banks operate at the very top of the healthcare M&A market. These firms are built to advise public companies and very large private equity–backed enterprises on transformational transactions, often involving complex financing structures, cross-border considerations, and capital markets execution.
Their healthcare practices typically sit alongside large corporate finance and capital markets platforms, making them well-suited for multi-billion-dollar mandates.
Goldman Sachs
Goldman Sachs is a dominant force in large-cap healthcare M&A, advising global pharmaceutical companies, medical device manufacturers, and diversified healthcare conglomerates. Its strength lies in complex strategic transactions, IPOs, and large-scale acquisitions where access to institutional capital and global investor networks is critical. Goldman’s healthcare clients are typically public companies or sponsor-backed enterprises operating at significant scale.
Keys Facts:
Founded: 1869, by Marcus Goldman
Headquarters: New York, United States
Employees: ~46,500
Market capitalization: ≈ $279 billion (Dec 2025)
| Summary of Online Reviews |
|---|
|
Online commentary regularly underscores Goldman Sachs’ strategic advisory capabilities and intellectual rigor, especially in transformative healthcare transactions. Clients often reference the firm’s role in shaping long-term strategic outcomes, noting its influence in high-stakes M&A, capital markets activity, and complex cross-border deals involving large healthcare organizations. |
J.P. Morgan
J.P. Morgan combines investment banking with one of the largest balance sheets in global finance, making it a preferred advisor for healthcare companies pursuing capital-intensive or highly structured transactions. The firm is particularly active in healthcare services, life sciences, and payer-related deals at the upper end of the market. Its client base generally consists of large corporates and private equity sponsors managing multi-billion-dollar portfolios.
Keys Facts:
Headquarters: New York City, U.S.
Global reach: Operations in 100+ countries
CEO (JPMorgan Chase): Jamie Dimon (2025)
Market capitalization: ≈ US $834 billion (2025)
| Summary of Online Reviews |
|---|
|
Clients and market observers frequently point to J.P. Morgan’s unmatched global reach and balance sheet strength, emphasizing the firm’s ability to execute large, complex healthcare transactions. Reviews often highlight its deep bench of sector specialists and disciplined execution on high-profile mandates, particularly for public companies and large private equity–backed businesses. |
Upper Middle Market Healthcare Companies
($200M–$1B transactions, $20–100M EBITDA)
Upper middle market healthcare banks serve scaled platforms, most often backed by private equity. These transactions typically involve recapitalizations, sponsor exits, or large add-on consolidations.
Many banks in this segment balance healthcare services and healthcare technology, with some leaning more heavily toward one than the other. These firms are well-positioned for institutional processes but often focus on transactions that meet minimum size thresholds.
Houlihan Lokey
Houlihan Lokey is one of the most active advisors in upper-middle-market healthcare M&A, with deep experience across healthcare services, life sciences, and healthcare IT. The firm frequently represents private equity sponsors and large platform companies, particularly in sponsor-to-sponsor transactions. Its scale and volume orientation make it a strong fit for larger healthcare enterprises with institutional ownership.
Keys Facts:
Founded: 1972
Headquarters: Los Angeles, California, United States
Employees: ≈2,700 (2025)
Market capitalization: ≈$12 billion (late 2025)
| Summary of Online Reviews |
|---|
|
Market commentary frequently notes Houlihan Lokey’s unmatched healthcare deal volume and highly disciplined execution, with many observers highlighting its ability to manage complex processes without losing momentum. |
William Blair
William Blair is known for its relationship-driven advisory model and strong healthcare franchise. The firm advises on a wide range of healthcare transactions, including services, medtech, and healthcare technology. William Blair’s clients are typically well-established private companies or PE-backed platforms seeking a strategic or financial exit at a meaningful scale.
Keys Facts:
Founded: 1935
Headquarters: Chicago, Illinois, U.S.
Employees: ~1,900 across 20+ offices worldwide
Client assets: About $82 billion (2025)
| Summary of Online Reviews |
|---|
|
Commentators frequently describe William Blair as providing thoughtful, research-backed strategic advice and white-glove support for management teams, especially in competitive sale processes. |
Cain Brothers
A boutique, Cain Brothers focuses almost exclusively on healthcare, with a long-standing reputation in healthcare services, health systems, and provider-based businesses. The firm frequently advises large nonprofit and for-profit healthcare organizations, as well as private equity–backed platforms. Its strengths are most evident in complex, institutionally scaled healthcare transactions.
Keys Facts:
Founded: 1982
Headquarters: New York City, United States
Specialization: Healthcare investment banking and advisory
Services: M&A advisory, capital raising, strategic consulting
| Summary of Online Reviews |
|---|
|
Industry sources highlight Cain Brothers’ deep healthcare focus and meticulous transaction preparation, with repeat clients noting that its sector specialists bring highly relevant insight to each deal. |
TripleTree
TripleTree specializes in healthcare technology and data-enabled healthcare services. The firm is particularly active in software, IT services, and analytics-driven healthcare businesses. While it’s healthcare services business has grown substantially, the bank’s historic focus is on technology-forward models with strong growth and scalability characteristics.
Keys Facts:
Founded: 1997
Headquarters: Minneapolis, Minnesota, USA
Industry focus: Healthcare technology, services, and pharma services
Parent company: Capital One (since 2021)
| Summary of Online Reviews |
|---|
|
Clients and internal testimonials emphasize TripleTree’s “exceptionally detailed up-front planning and diligence” and “highly tailored processes that make investors lean in” to opportunities, even when markets are volatile. |
Piper Sandler
Piper Sandler maintains a broad healthcare investment banking practice spanning services, medtech, and healthcare IT. The firm often advises larger private companies and sponsor-backed platforms, with an emphasis on transactions that can support institutional buyer processes and public-market-style diligence.
Keys Facts:
Founded: 1895
Headquarters: Minneapolis, Minnesota, U.S.
Employees: ~1,800 (2025)
Market capitalization: ≈ $6.3 billion (Dec 2025)
| Summary of Online Reviews |
|---|
|
Clients and observers often reference Piper Sandler’s best-in-class sector knowledge and high-touch deal teams, noting that its bankers are deeply involved in both strategic positioning and day-to-day execution. |
Lower Middle Market Healthcare Companies
($20M–$200M transactions, $2–20M EBITDA)
The lower middle market represents one of the most active yet underserved segments in healthcare mergers and acquisitions (M&A). These businesses are often founder-owned, regionally concentrated, and operationally complex, yet too small to command consistent attention from large middle-market banks. Transactions in this range typically involve sales to private equity groups or PE-backed platforms seeking to expand their platforms.
FOCUS Investment Banking
FOCUS Investment Banking’s healthcare group was built specifically to serve healthcare companies in this narrow size band. The firm delivers a full institutional M&A process to businesses that fall below the deal size thresholds of most upper middle market competitors. The healthcare group maintains a laser focus on healthcare services and related sectors, allowing it to bring deep buyer knowledge, operational understanding, and tailored positioning to founder-owned businesses.
Unlike larger banks that prioritize scale, FOCUS emphasizes premium service, senior banker involvement, and process rigor for transactions that are often transformational for owners. This specialization has made FOCUS a preferred advisor for healthcare entrepreneurs seeking private equity partners or strategic buyers without being deprioritized due to deal size.
Keys Facts:
Founded: 1982
Headquarters: Washington, D.C., United States
Employees: 51–200
Global footprint: Offices in Atlanta, Los Angeles, Dublin, and Limerick
| Summary of Online Reviews |
|---|
|
Clients often describe FOCUS’s healthcare team as providing “smooth guidance through the entire process” and having “patient, highly responsive senior bankers” who explain each step clearly and keep deals on track. |
Small Healthcare Transactions
(Transactions under $20M, under $2M EBITDA)
Smaller healthcare transactions typically involve owner-operated businesses and buyers such as individual operators or local strategic acquirers. These deals generally do not require broad institutional buyer coverage or complex transaction structures.
Transworld Business Brokers
Transworld Business Brokers operates a large network of local brokers focused on small business sales across many industries, including healthcare. Its model is best suited for relatively straightforward transactions involving smaller practices or service businesses.
Keys Facts:
Founded: 1979
Headquarters: West Palm Beach, Florida, USA
Scale: 250+ offices and 1,000+ brokers worldwide (franchise network)
Core services: Business sales, mergers and acquisitions, franchise sales, and consulting
| Summary of Online Reviews |
|---|
|
Reviews commonly describe Transworld Business Brokers as a broadly accessible, locally oriented brokerage network, valued for its reach across small business markets. Feedback often notes the firm’s structured sales process and familiarity with owner-operated transactions, particularly for businesses seeking individual or regional buyers rather than institutional capital. |
If you’d like to learn more about our healthcare investment banking services, reach out here.
